Create your free financial workspace to save stocks, track your portfolio, set price alerts, and personalize TickerPulse for your financial goals.
Analyze fundamentals, valuation multiples, margin resilience, and balance sheet debt across 2 to 4 companies with zero bias.
| Metric / Company |
GL
GLAXO
GLAXOSMITHKLINE PHARMA LT
|
NE
NEULANDLAB
NEULAND LAB Ltd.
|
|---|---|---|
| Current Share Price |
₹2,799.90
▼ 0.00 (-1.97%)
|
₹22,665.00
▲ +0.00 (+0.18%)
|
| Market Capitalization | ₹15,250,500.00L Cr | ₹115,050,000.00L Cr |
| Sector | Healthcare & Pharma | Healthcare & Pharma |
| Overall Quality Score | 65 / 100 | 65 / 100 |
| P/E Ratio (TTM) |
28.5x LOWEST P/E |
28.5x LOWEST P/E |
| Return on Equity (ROE) |
16.4% HIGHEST ROE |
16.4% HIGHEST ROE |
| Debt / Equity Ratio |
0.25 LEAST DEBT |
0.25 LEAST DEBT |
| Operating Margin | — | — |
| Dividend Yield | 0.85% | 0.85% |
| Annual Free Cash Flow | ₹0.00 Cr | ₹0.00 Cr |
| Full GLAXO Report → | Full NEULANDLAB Report → |